MSCLF
Price
$0.47
Change
-$0.05 (-9.62%)
Updated
Jul 2 closing price
Capitalization
76.58M
NEUP
Price
$7.13
Change
+$0.11 (+1.57%)
Updated
Jul 3 closing price
Capitalization
13.4M
Interact to see
Advertisement

MSCLF vs NEUP

Header iconMSCLF vs NEUP Comparison
Open Charts MSCLF vs NEUPBanner chart's image
SATELLOS BIOSCIENCE
Price$0.47
Change-$0.05 (-9.62%)
Volume$177.73K
Capitalization76.58M
Neuphoria Therapeutics
Price$7.13
Change+$0.11 (+1.57%)
Volume$15.12K
Capitalization13.4M
MSCLF vs NEUP Comparison Chart in %
Loading...
MSCLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MSCLF vs. NEUP commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSCLF is a StrongBuy and NEUP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (MSCLF: $0.47 vs. NEUP: $7.13)
Brand notoriety: MSCLF and NEUP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MSCLF: 200% vs. NEUP: 60%
Market capitalization -- MSCLF: $76.58M vs. NEUP: $13.4M
MSCLF [@Biotechnology] is valued at $76.58M. NEUP’s [@Biotechnology] market capitalization is $13.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MSCLF’s FA Score shows that 0 FA rating(s) are green whileNEUP’s FA Score has 1 green FA rating(s).

  • MSCLF’s FA Score: 0 green, 5 red.
  • NEUP’s FA Score: 1 green, 4 red.
According to our system of comparison, NEUP is a better buy in the long-term than MSCLF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MSCLF’s TA Score shows that 5 TA indicator(s) are bullish while NEUP’s TA Score has 5 bullish TA indicator(s).

  • MSCLF’s TA Score: 5 bullish, 3 bearish.
  • NEUP’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both MSCLF and NEUP are a good buy in the short-term.

Price Growth

MSCLF (@Biotechnology) experienced а +5.27% price change this week, while NEUP (@Biotechnology) price change was +4.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

MSCLF is expected to report earnings on May 13, 2025.

NEUP is expected to report earnings on May 20, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MSCLF($76.6M) has a higher market cap than NEUP($13.4M). MSCLF has higher P/E ratio than NEUP: MSCLF (2.55) vs NEUP (0.38). NEUP YTD gains are higher at: 107.872 vs. MSCLF (-20.246). NEUP has higher annual earnings (EBITDA): 192K vs. MSCLF (-19.92M). MSCLF has more cash in the bank: 41.2M vs. NEUP (17M). NEUP has higher revenues than MSCLF: NEUP (15.7M) vs MSCLF (0).
MSCLFNEUPMSCLF / NEUP
Capitalization76.6M13.4M572%
EBITDA-19.92M192K-10,373%
Gain YTD-20.246107.872-19%
P/E Ratio2.550.38675%
Revenue015.7M-
Total Cash41.2M17M242%
Total DebtN/A172K-
FUNDAMENTALS RATINGS
MSCLF: Fundamental Ratings
MSCLF
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
64
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MSCLFNEUP
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 5 days ago
75%
Bullish Trend 6 days ago
89%
Declines
ODDS (%)
N/A
Bearish Trend 20 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
81%
Aroon
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MSCLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JFBC21.160.04
+0.19%
Jeffersonville Bancorp
AEMMY11.28N/A
N/A
A2A SpA
FULO0.39N/A
N/A
FullNet Communications, Inc.
DSDVY120.23-0.21
-0.17%
DSV A S
AAVVF8.41-0.14
-1.64%
Advantage Energy Ltd.

MSCLF and

Correlation & Price change

A.I.dvisor tells us that MSCLF and AKBLF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MSCLF and AKBLF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MSCLF
1D Price
Change %
MSCLF100%
N/A
AKBLF - MSCLF
27%
Poorly correlated
N/A
CDIO - MSCLF
20%
Poorly correlated
+3.26%
IMMX - MSCLF
12%
Poorly correlated
+16.44%
NRSN - MSCLF
11%
Poorly correlated
+0.53%
NEUP - MSCLF
8%
Poorly correlated
+1.57%
More

NEUP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEUP has been loosely correlated with SYBX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if NEUP jumps, then SYBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEUP
1D Price
Change %
NEUP100%
+1.57%
SYBX - NEUP
64%
Loosely correlated
-1.67%
BRNS - NEUP
50%
Loosely correlated
-2.63%
CMND - NEUP
31%
Poorly correlated
+21.82%
ENSC - NEUP
31%
Poorly correlated
+1.76%
SLNO - NEUP
27%
Poorly correlated
+0.51%
More